ClinicalTrials.gov
public full text
Public Domain
Determining the Amount of Time Needed for Nelfinavir to Boost the Immune System in Adults
Our group has shown that HAART increases the thymic production of naïve T cells in the healthy adult, thereby boosting the immune system. We propose to investigate the amount of and length of Nelfinavir therapy necessary to increase those cells in adults. Subjects will be treated with Nelfinavir, and blood will be sampled at variable times to determine the immune response in peripheral blood.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- The Exploratory Study on the Nicotinamide Mononucleotide (Vital NAD ) to Promote the Rejuvenation of the Peripheral Blood Immune Cells of Adults.#870158
- Coagulation factor V is a T-cell inhibitor expressed by leukocytes in COVID-19#1005429
- Immune Responses to HIV in Blood Cells in HIV-Infected and HIV-Uninfected Volunteers#825155
- The Changes of CD4+T Lymphocyte Subsets in Septic Patients#881342
- High concentrations of Maraviroc do not alter immunological and metabolic parameters of CD4 T cells#284299
Record · ID 1126922
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive